Startups

Anaconda Biomed
Sant Quirze del Vallès, Barcelona, Spain
Anaconda Biomed S.L. is a Barcelona-area medical-device company developing funnel-based endovascular access and protection technology for neurovascular interventions, including mechanical thrombectomy in acute ischemic stroke caused by large-vessel occlusion. Co-founded in2015 by neurologist Marc Ribó and biomedical materials scientist Ofir Arad, it is registered in Spain under tax numberB66513474 and manufactures in Sant Quirze del Vallès. Its platform combines a self-expanding nitinol funnel, aspiration and temporary vascular-flow restriction, with devices intended to support clot retrieval and reduce downstream embolization. Clinical outcomes remain subject to the relevant product studies and indications. The issuer identifies ANA5 as CE-mark approved and the ANA Funnel Catheter as investigational-only in the United States. Its ongoing ATHENA pivotal IDE study is a prospective randomized327-subject trial. Trent Reutiman leads the company asCEO, alongside a published eight-person management team, external clinical scientific advisers and board representatives from its specialist healthcare investors. A closedUSD56M financing announced September23,2026 supports clinical development, manufacturing and regulatory work; the record separately identifies prior equity financings, investment commitments, public grant support and its signed EIB venture-debt facility.
Founded 2015

















